stoxline Quote Chart Rank Option Currency Glossary
  
Scienture Holdings, Inc. (SCNX)
3.01  -0.24 (-7.38%)    02-12 16:12
Open: 3.2
High: 3.2
Volume: 3,439
  
Pre. Close: 3.25
Low: 3.01
Market Cap: 27(M)
Technical analysis
2025-02-12 4:47:54 PM
Short term     
Mid term     
Targets 6-month :  5.65 1-year :  6.98
Resists First :  4.84 Second :  5.98
Pivot price 3.68
Supports First :  3 Second :  2.5
MAs MA(5) :  3.25 MA(20) :  3.87
MA(100) :  6.59 MA(250) :  8.7
MACD MACD :  -0.7 Signal :  -0.7
%K %D K(14,3) :  7 D(3) :  9.2
RSI RSI(14): 23.3
52-week High :  44.56 Low :  3
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SCNX ] has closed above bottom band by 4.0%. Bollinger Bands are 16.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.2 - 3.23 3.23 - 3.25
Low: 2.96 - 2.99 2.99 - 3
Close: 2.97 - 3.02 3.02 - 3.05
Company Description

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

Headline News

Fri, 31 Jan 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Fri, 31 Jan 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Tue, 21 Jan 2025
Scienture Holdings, Inc. Announces Dr. Narasimhan Mani's Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics - The Manila Times

Tue, 17 Dec 2024
Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025 - GlobeNewswire

Tue, 10 Dec 2024
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041 - GlobeNewswire

Fri, 30 Jun 2023
TRxADE Health Agrees to Buy Superlatus -June 30, 2023 at 08:57 am EDT - Marketscreener.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 0 (M)
Shares Float 9 (M)
Held by Insiders 7.85e+006 (%)
Held by Institutions 51.7 (%)
Shares Short 9 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -5 %
Return on Assets (ttm) 392.7 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -351610 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -20.3 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -12 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 11580
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android